Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1987-10-9
|
pubmed:abstractText |
A series of lymphoblastoid cell lines (LCLs) have been established by in vitro infection of fetal bone marrow and fetal liver cells with Epstein-Barr virus (EBV). While most lines showed the usual mature B cell phenotype, a small proportion were cytoplasmic and surface immunoglobulin (Ig) heavy and light chain negative. Analysis of gene rearrangements indicated that the Ig- lines were either germ-line or nonproductively rearranged when probed for JH and were in germ-line configuration for C chi; no mu or chi mRNA could be detected in such cells. Precursor B cell lines were indistinguishable from their normal Ig+ counterparts in their expression of a wide variety of cell surface markers including "activation" antigens usually associated with the lymphoblastoid state; even the single LCL showing germ-line heavy and light chain genes expressed B lineage-specific cell surface antigens. However, the Ig- lines were distinct from their Ig+ counterparts in three important respects: (a) they grew much more slowly and achieved lower saturation densities, (b) they showed unusually high proportions (8-16%) of cells in EBV-productive cycle, and (c) they contained unusually high proportions (up to 40%) of cells expressing free joining (J) chain. These results suggest that precursor B cells differ in their response to the growth-transforming effects of EBV such that the virus-cell interaction in precursor B cell lines is inherently less stable than in conventional LCL. In particular there may be a greater movement of cells out of cycle and along the B cell maturation pathway. It is possible that such movement leads in individual cells either to virus replication or to a "sterile" plasmacytoid differentiation with J chain expression in the absence of Ig synthesis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0014-2980
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1199-207
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3040424-Antibody Formation,
pubmed-meshheading:3040424-B-Lymphocytes,
pubmed-meshheading:3040424-Bone Marrow,
pubmed-meshheading:3040424-Bone Marrow Cells,
pubmed-meshheading:3040424-Cell Differentiation,
pubmed-meshheading:3040424-Cell Division,
pubmed-meshheading:3040424-Cell Transformation, Viral,
pubmed-meshheading:3040424-Gene Expression Regulation,
pubmed-meshheading:3040424-Genes,
pubmed-meshheading:3040424-Herpesvirus 4, Human,
pubmed-meshheading:3040424-Humans,
pubmed-meshheading:3040424-Immunoglobulin Heavy Chains,
pubmed-meshheading:3040424-Liver,
pubmed-meshheading:3040424-RNA, Messenger,
pubmed-meshheading:3040424-Receptors, Antigen, B-Cell
|
pubmed:year |
1987
|
pubmed:articleTitle |
Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germ-line or rearranged but nonexpressed heavy chain genes.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|